Brought to you by 
Konica Minolta buys Ambry Genetics for $800mm cash plus earn-outs
17 Nov 2017
Executive Summary
In a push to expand its health care offerings with an emphasis on precision medicine, Konica Minolta Inc. agreed to pay $800mm cash to acquire privately held genetic testing firm Ambry Genetics Corp. The deal also includes up to $200mm in earn-outs based on financial achievements.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Laboratory Testing Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com